Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study
Authors:
- Marion LeboyerMLMarion Leboyer
- Jean-Marie LaunayJLJean-Marie Launay
- Christophe RecasensCRChristophe Recasens
- Marie-Hélène PlumetMPMarie-Hélène Plumet
- Delphine Waller-PerotteDWDelphine Waller-Perotte
- François TabuteauFTFrançois Tabuteau
- Dominique BondouxDBDominique Bondoux
- Michel DugasMDMichel Dugas
- Patrick LensingPLPatrick Lensing
- Jaak PankseppJPJaak Panksepp
- 1 October 1995
- journal article
- clinical trial
- Published by Elsevier in Psychiatry Research
- Vol. 58 (3) , 191-201
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Naltrexone in Autistic Children: Behavioral Symptoms and Attentional LearningJournal of the American Academy of Child & Adolescent Psychiatry, 1993
- Brief report: A double-blind study of naltrexone in infantile autismJournal of Autism and Developmental Disorders, 1992
- The behavioral summarized evaluation: Validity and reliability of a scale for the assessment of autistic behaviorsJournal of Autism and Developmental Disorders, 1990
- CSF beta-endorphins in childhood neuropsychiatric disordersBrain and Development, 1990
- EFFECTS OF NALTREXONE ON INFANTILE AUTISMThe Lancet, 1988
- Naltrexone decreases self‐injurious behaviorAnnals of Neurology, 1987
- Endorphin Activity in Childhood PsychosisArchives of General Psychiatry, 1985
- β-Endorphin concentrations in serum, hypothalamus and central gray of hypophysectomized and mediobasal hypothalamus lesioned ratsBrain Research, 1982
- Normative data on Revised Conners Parent and Teacher Rating ScalesJournal of Abnormal Child Psychology, 1978
- Radioimmunoassays for α-endorphin and β-endorphinBiochemical and Biophysical Research Communications, 1977